SQZ Biotechnologies is a cutting-edge biotech company based in Watertown, MA, dedicated to unlocking the full potential of cell therapies for patients worldwide. Through their proprietary Cell Squeeze technology, they effectively deliver therapeutic cargo to cells at scale while preserving cell function, opening up new possibilities for cell therapies in oncology, autoimmune, and infectious diseases.
The company is actively enrolling patients in clinical trials for their cell therapies, including targeting HPV16 solid tumors. With their SQZ eAPC and SQZ AAC platforms, they aim to activate CD8 T cells against disease using a patient's own white blood cells, multiple mRNAs, red blood cells, peptide antigens, and an adjuvant. SQZ Biotechnologies is committed to advancing the field of cell therapies and providing educational resources through their #HowCellsWork series.
Generated from the website